Faced with many regulatory bottlenecks, the European cell therapy community must unite and confront these challenges head-on. The 3rd Cell Therapy Analytical Development Summit Europe is your unmissable opportunity to connect with peers, share pain points and establish analytical standards for smoother interactions with regulatory bodies including the FDA, EMA and MHRA.
Prices: GBP 1799.00 - GBP 4297.00
Speakers
Alison Caldwell, Group Lead, Analytical Development, Resolution Therapeutics, Amanda Versteilen, Associate Director Analytical QC, Bristol Myers Squibb, Andreea Iftimia Mander, Head of Analytical and Biological Sciences, Medicines and Healthcare products Regulatory Agency, Arindam Mitra, Director, CMC, Leucid Bio, Aurelien Bunga, Senior Scientist, Rinri Therapeutics, Benjamin Espen, Principal Quality Engineer, Avobis Bio, and more
Science